Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Gastric HER2/Claudin18.2

Florian Lordick

MD

🏢University of Leipzig🌐Germany

Director, University Cancer Center Leipzig

65
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Florian Lordick is a prominent European leader in gastroesophageal cancer research and multidisciplinary treatment. He has contributed significantly to clinical trials evaluating HER2 and Claudin 18.2-targeted therapies including zolbetuximab. His work on perioperative and palliative treatment strategies has shaped European treatment guidelines.

Share:

🧪Research Fields 研究领域

Gastric cancer
Esophageal cancer
HER2 therapy
Claudin 18.2 targeting
Multimodal treatment

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Florian Lordick 的研究动态

Follow Florian Lordick's research updates

留下邮箱,当我们发布与 Florian Lordick(University of Leipzig)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment